These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 23969222)
41. Three-Year Outcomes of Biodegradable Polymer-Coated Ultra-Thin (60 µm) Sirolimus-Eluting Stents in Real-World Clinical Practice. Chandwani P; Meel B; Singhal R; Jangid K; Ahmed R; Yadav M; Gupta AK; Chopra R Ann Acad Med Singap; 2019 May; 48(5):150-155. PubMed ID: 31210252 [TBL] [Abstract][Full Text] [Related]
42. Clinical outcome of titanium-nitride-oxide-coated cobalt-chromium stents in patients with de novo coronary lesions: 12-month results of the OPTIMAX first-in-man study. Karjalainen PP; Mikkelsson J; Paana T; Nammas W Catheter Cardiovasc Interv; 2016 Mar; 87(4):E122-7. PubMed ID: 26308878 [TBL] [Abstract][Full Text] [Related]
43. Long-term clinical outcomes of a crystalline sirolimus-eluting coronary stent with a fully bioabsorbable polymer coating: five-year outcomes from the DESSOLVE I and II trials. Wijns W; Vrolix M; Verheye S; Schoors D; Slagboom T; Gosselink M; Benit E; Kandzari D; Donohoe D; Ormiston JA EuroIntervention; 2018 Apr; 13(18):e2147-e2151. PubMed ID: 29278354 [TBL] [Abstract][Full Text] [Related]
44. Immediate and 1-year follow-up with the novel nanosurface modified COBRA PzF stent. Maillard L; Tavildari A; Barra N; Billé J; Joly P; Peycher P; Silvestri M; Vochelet F Arch Cardiovasc Dis; 2017 Dec; 110(12):682-688. PubMed ID: 29102364 [TBL] [Abstract][Full Text] [Related]
45. Long-term prognosis of complete percutaneous coronary revascularisation in patients with diabetes with multivessel disease. Jiménez-Navarro MF; López-Jiménez F; Barsness G; Lennon RJ; Sandhu GS; Prasad A Heart; 2015 Aug; 101(15):1233-9. PubMed ID: 25882502 [TBL] [Abstract][Full Text] [Related]
46. Pivotal trial to evaluate the safety and efficacy of the orbital atherectomy system in treating de novo, severely calcified coronary lesions (ORBIT II). Chambers JW; Feldman RL; Himmelstein SI; Bhatheja R; Villa AE; Strickman NE; Shlofmitz RA; Dulas DD; Arab D; Khanna PK; Lee AC; Ghali MG; Shah RR; Davis TP; Kim CY; Tai Z; Patel KC; Puma JA; Makam P; Bertolet BD; Nseir GY JACC Cardiovasc Interv; 2014 May; 7(5):510-8. PubMed ID: 24852804 [TBL] [Abstract][Full Text] [Related]
47. The effect of complete percutaneous revascularisation with and without intravascular ultrasound guidance in the drugeluting stent era. Magalhaes MA; Minha S; Torguson R; Baker NC; Escarcega RO; Omar AF; Lipinski MJ; Chen F; Suddath WO; Satler LF; Pichard AD; Waksman R EuroIntervention; 2015 Oct; 11(6):625-33. PubMed ID: 26499219 [TBL] [Abstract][Full Text] [Related]
48. Coronary artery aneurysm occurring very late after drug-eluting stent implantation. Okamura K; Suematsu Y; Morizumi S; Kawata M Interact Cardiovasc Thorac Surg; 2014 Dec; 19(6):1068-70. PubMed ID: 25164132 [TBL] [Abstract][Full Text] [Related]
49. Sirolimus-eluting stent treatment for isolated proximal left anterior descending artery stenoses. Results from the prospective multi-center German Cypher Registry. Khattab AA; Hamm CW; Senges J; Toelg R; Geist V; Bonzel T; Kelm M; Levenson B; Nienaber CA; Sabin G; Schneider S; Tebbe U; Richardt G Z Kardiol; 2005 Mar; 94(3):187-92. PubMed ID: 15747041 [TBL] [Abstract][Full Text] [Related]
50. A Nuclear Magnetic Resonance Spectroscopy as a Method for Evaluation of In Vivo Poly-l-Lactide Biodegradation Kinetics From Stent-Polymer Matrices: An Experimental Study Utilizing Porcine Model of In-Stent Restenosis. Orlik B; Buszman PP; Krauze A; Gąsior P; Desperak P; Pająk J; Kasperczyk J; Janas A; Jelonek M; Handzlik-Orlik G; Buszman PE; Milewski K J Cardiovasc Pharmacol Ther; 2016 Jan; 21(1):93-9. PubMed ID: 25944843 [TBL] [Abstract][Full Text] [Related]
51. Elective versus deferred stenting following subintimal recanalization of coronary chronic total occlusions. Visconti G; Focaccio A; Donahue M; Briguori C Catheter Cardiovasc Interv; 2015 Feb; 85(3):382-90. PubMed ID: 24740711 [TBL] [Abstract][Full Text] [Related]
52. Is there a need for distal protection during native vessel percutaneous coronary intervention in patients with stable coronary artery disease? Hildebrandt HA; Kahlert P; Baars T; Kleinbongard P; Erbel R; Heusch G J Cardiovasc Med (Hagerstown); 2014 Feb; 15(2):170-2. PubMed ID: 23846674 [No Abstract] [Full Text] [Related]
53. Long-term follow-up after coronary stenting with the sirolimus-eluting stent in clinical practice: results from the prospective multi-center German Cypher Stent Registry. Zahn R; Neumann FJ; Büttner HJ; Richardt G; Schneider S; Levenson B; Tebbe U; Sabin G; Nienaber CA; Pfannebecker T; Hamm CW Clin Res Cardiol; 2012 Sep; 101(9):709-16. PubMed ID: 22485014 [TBL] [Abstract][Full Text] [Related]
54. Long-term safety and performance of the orbital atherectomy system for treating calcified coronary artery lesions: 5-Year follow-up in the ORBIT I trial. Bhatt P; Parikh P; Patel A; Chag M; Chandarana A; Parikh R; Parikh K Cardiovasc Revasc Med; 2015 Jun; 16(4):213-6. PubMed ID: 25866032 [TBL] [Abstract][Full Text] [Related]
55. Acute closure after stenting: not always a thrombus. Badr S; Dvir D; Pichard AD; Waksman R Catheter Cardiovasc Interv; 2013 Nov; 82(5):765-7. PubMed ID: 23239619 [TBL] [Abstract][Full Text] [Related]
56. Novel use of a stent graft for uncontrollable intraprocedural stent thrombosis in a patient with acute myocardial infarction. Inoguchi Y; Kaku B; Kitagawa N; Katsuda S Catheter Cardiovasc Interv; 2020 Mar; 95(4):713-717. PubMed ID: 31141303 [TBL] [Abstract][Full Text] [Related]